Tezval, Hossein <br/><br/>
The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.  [electronic resource] 

 -  The Prostate  Mar 2009 
 - 443-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0045 
<br/><br/><label>Standard No.: </label>10.1002/pros.20892  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood supply<br/>Aged<br/>Apoptosis--physiology<br/>Cell Proliferation<br/>Down-Regulation--physiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Neovascularization, Pathologic--metabolism<br/>Prostate--cytology<br/>Prostatic Neoplasms--blood supply<br/>RNA, Messenger--metabolism<br/>Receptors, Corticotropin-Releasing Hormone--metabolism<br/>Signal Transduction--physiology<br/>Urocortins--metabolism